Literature DB >> 12567143

Postoperative progression of pulmonary metastasis in osteosarcoma.

Takeo Tsunemi1, Satoshi Nagoya, Mitsunori Kaya, Satoshi Kawaguchi, Takuro Wada, Toshihiko Yamashita, Seiichi Ishii.   

Abstract

Early relapse with distant metastasis often is observed in patients with cancer after resection of the primary tumor. It is considered that resection of the primary tumor induces activation of systemic angiogenesis and enhances progression of remote metastasis. The authors show that resection of the primary osteosarcoma tumor enhances progression of pulmonary metastasis in animal osteosarcoma models. Matrigel plug neovascularization assay revealed that systemic angiogenic activity was elevated after primary tumor removal (tumor intact group, 1.61 +/- 0.21 g/dL; tumor removed group, 4.92 +/- 0.35 g/dL). In addition, serum concentration of the angiogenesis inhibitor, endostatin, decreased significantly after primary tumor removal. Treatment with the antiangiogenic reagent TNP-470 suppressed postoperative progression of pulmonary metastasis. These results indicate the possibility that activation of angiogenic activity after resection of osteosarcoma tumors enhances progression of pulmonary metastasis. The current data also suggest that administration of antiangiogenic reagents can prevent progression of pulmonary metastasis in osteosarcoma postoperatively.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12567143     DOI: 10.1097/00003086-200302000-00024

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  20 in total

1.  Transtumoral plating as a novel method for palliative limb spare and thromboembolism in a dog with a distal radial primary bone tumor.

Authors:  Sarah E Boston; Maureen Barry; M Lynne O'Sullivan
Journal:  Can Vet J       Date:  2011-06       Impact factor: 1.008

2.  Clinical Genomic Sequencing of Pediatric and Adult Osteosarcoma Reveals Distinct Molecular Subsets with Potentially Targetable Alterations.

Authors:  Yoshiyuki Suehara; Deepu Alex; Anita Bowman; Sumit Middha; Ahmet Zehir; Debyani Chakravarty; Lu Wang; George Jour; Khedoudja Nafa; Takuo Hayashi; Achim A Jungbluth; Denise Frosina; Emily Slotkin; Neerav Shukla; Paul Meyers; John H Healey; Meera Hameed; Marc Ladanyi
Journal:  Clin Cancer Res       Date:  2019-06-07       Impact factor: 12.531

3.  The metastasectomy and timing of pulmonary metastases on the outcome of osteosarcoma patients.

Authors:  Yu-Min Huang; Chun-Han Hou; Sheng-Mou Hou; Rong-Sen Yang
Journal:  Clin Med Oncol       Date:  2009-09-14

4.  Neoadjuvant multidrug chemotherapy including high-dose methotrexate modifies VEGF expression in osteosarcoma: an immunohistochemical analysis.

Authors:  Barbara Rossi; Giovanni Schinzari; Giulio Maccauro; Laura Scaramuzzo; Diego Signorelli; Michele A Rosa; Carlo Fabbriciani; Barone Carlo
Journal:  BMC Musculoskelet Disord       Date:  2010-02-16       Impact factor: 2.362

5.  Molecule action mechanisms of NM-3 on human gastric cancer SGC-7901 cells in vivo or in vitro.

Authors:  Jin-Shui Zhu; Bo Shen; Jin-Lian Chen; Guo-Qiang Chen; Xiao-Hu Yu; Hua-Fang Yu; Zu-Ming Zhu
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

6.  Synergistic antitumor efficacy by combining adriamycin with recombinant human endostatin in an osteosarcoma model.

Authors:  Hairong Xu; Xiaohui Niu; Qing Zhang; Lin Hao; Yi Ding; Weifeng Liu; Lu Yao
Journal:  Oncol Lett       Date:  2011-07-04       Impact factor: 2.967

7.  Angiogenic and antiangiogenic balance regulates concomitant antitumoral resistance.

Authors:  O Graciela Scharovsky; M Mercedes Binda; Viviana R Rozados; Sunita Bhagat; Michael L Cher; R Daniel Bonfil
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

8.  Effect of ascorbic acid, lysine, proline, and green tea extract on human osteosarcoma cell line MNNG-HOS xenografts in nude mice: evaluation of tumor growth and immunohistochemistry.

Authors:  M Waheed Roomi; Vadim Ivanov; Tatiana Kalinovsky; Aleksandra Niedzwiecki; Matthias Rath
Journal:  Med Oncol       Date:  2006       Impact factor: 3.738

9.  Promising development from translational or perhaps anti-translational research in breast cancer.

Authors:  Michael Retsky; Romano Demicheli; William Jm Hrushesky; Patrice Forget; Marc De Kock; Isaac Gukas; Rick A Rogers; Michael Baum; Katharine Pachmann; Jayant S Vaidya
Journal:  Clin Transl Med       Date:  2012-08-28

10.  Endostatin expression in pancreatic tissue is modulated by elastase.

Authors:  R D Brammer; S R Bramhall; M C Eggo
Journal:  Br J Cancer       Date:  2005-01-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.